A critical assessment of the role of antiphospholipid antibodies in infertility

Journal of Reproductive Immunology

Volumn 80, Issue 1-2, 2009, Pages 132-145

  Buckingham, K L ^a,b   Chamley, L W ^a,b  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b GREEN LANE HOSPITAL   (New Zealand)

Author keywords

Anticardiolipin antibodies; Antiphospholipid antibodies; In vitro fertilization; Infertility; Lupus anticoagulant

Indexed keywords

ACETYLSALICYLIC ACID; EPITOPE; HEPARIN; IMMUNOGLOBULIN; PHOSPHOLIPID ANTIBODY; PLACEBO; PREDNISONE;

ANTIPHOSPHOLIPID SYNDROME; ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE FERTILITY; FEMALE INFERTILITY; FERTILIZATION IN VITRO; HUMAN; LOW DRUG DOSE; MATERNAL BLOOD; MEDICAL LITERATURE; OUTCOME ASSESSMENT; PREVALENCE; PRIORITY JOURNAL; SPONTANEOUS ABORTION; SYSTEMIC LUPUS ERYTHEMATOSUS; TREATMENT FAILURE; ZYGOTE;

ABORTION, HABITUAL; ANIMALS; ANTIBODIES, ANTIPHOSPHOLIPID; ASPIRIN; CLINICAL TRIALS AS TOPIC; DRUG THERAPY, COMBINATION; EPITOPES; FEMALE; FERTILIZATION IN VITRO; HEPARIN; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; INCIDENCE; INFERTILITY, FEMALE; META-ANALYSIS AS TOPIC; PREDNISONE; PREGNANCY; PROGNOSIS; STILLBIRTH; TREATMENT OUTCOME;

EID: 67349174287     PISSN: 01650378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jri.2008.11.005     Document Type: Article

References (51)

1. Azem F., Geva E., Amit A., Lerner-Geva L., Shwartz T., Ben-Yosef D., Yovel I., and Lessing J. High levels of anticardiolipin antibodies in patients with abnormal embryo morphology who attended an in vitro fertilisation program. Am. J. Reprod. Immunol. 39 (1998) 161-163
2. Balasch J., Creus M., Fábrèques F., Reverter J., Carmona F., Tàssies D., Font J., and Vanrell J. Antiphospholipid antibodies and human reproductive failure. Hum. Reprod. 11 (1996) 2310-2315
3. Balasch J., Creus M., Fábrèques F., Cívico S., Reverter J., Carmona F., Tàssies D., and Vanrell J. Antiphospholipid antibodies and the outcome of pregnancy after the first in-vitro fertilization and embryo transfer cycle. Hum. Reprod. 13 (1998) 1180-1183
4. Birdsall M., Lockwood G., Ledger W., Johnson P., and Chamley L. Antiphospholipid antibodies in women having in-vitro fertilization. Hum. Reprod. 11 (1996) 1185-1189
5. Birkenfeld A., Mukaida T., Minichiello L., Jackson M., Kase N., and Yemini M. Incidence of autoimmune antibodies in failed embryo transfer cycles. Am. J. Reprod. Immunol. 31 (1994) 65-68
6. Blank M., Cohen J., Toder V., and Shoenfeld Y. Induction of anti-phospholipid syndrome in naive mice with mouse lupus monoclonal and human polyclonal anti-cardiolipin antibodies. Proc. Natl. Acad. Sci. U.S.A. 88 (1991) 3069-3073
7. Branch D., Dudley D., Mitchell M., Creighton K., Abbott T., and Hammond E. Immunoglobulin G fractions from patients with antiphospholipid antibodies cause fetal death in BALB/c mice: a model for autoimmune fetal loss. Am. J. Obstet. Gynecol. 163 (1990) 210-216
8. Buckingham K., Stone P., Smith J., and Chamley L. Antiphospholipid antibodies in serum and follicular fluid-is there a correlation with IVF implantation failure?. Hum. Reprod. 21 (2006) 728-734
9. Chavez D., and McIntyre J. Sera from women with histories of repeated pregnancy losses cause abnormalities in mouse peri-implantation blastocysts. J. Reprod. Immunol. 6 (1984) 273-281
10. Chilcott I., Margara R., Cohen H., Rai R., Skull J., Pickering W., and Regan L. Pregnancy outcome is not affected by antiphospholipid antibody status in women referred for in vitro fertilization. Fertil. Steril. 73 (2000) 526-530
11. Coulam C., Kaider B., Kaider A., Janovicz P., and Roussev R. Antiphospholipid antibodies associated with implantation failure after IVRF/ET. J. Assist. Reprod. Genet. 14 (1997) 602-608
12. Denis A., Bergh P., Guido M., Brenner C., Adler R., and Scott R. Antiphospholipid antibodies and pregnancy rates and outcome in in vitro fertilization patients. Fertil. Steril. 67 (1997) 1084-1090
13. Dmowski W., Rana N., Michalowski J., Fribert J., Papierniak C., and el-Roeiy A. The effect of endometriosis, its stage and activity, and of autoantibodies on in vitro fertilization and embryo transfer success rates. Fertil. Steril. 63 (1995) 555-562
14. Eldar-Geva T., Wood C., Lolatgis N., Rombauts I., Kovacs G., Fuscaldo J., and Trounson A. Cumulative pregnancy and live birth rates in women with antiphospholipid antibodies undergoing assisted reproduction. Hum. Reprod. 14 (1999) 1461-1466
15. El-Roeiy A., and Gleicher N. Definition of normal autoantibody levels in an apparently healthy population. Obstet. Gynecol. 72 (1988) 596-602
16. El-Roeiy A., Gleicher N., Friberg J., Confino E., and Dudkiewicz A. Correlation between peripheral blood and follicular fluid autoantibodies and impact on in vitro fertilization. Obstet. Gynecol. (1987) 70
17. Empson, M., Lassere, M., Craig, J., Scott, J., 2005. Prevention of recurrent miscarriage for women with antiphospholipid antibody or lupus anticoagulant. Cochrane Database Syst. Rev. Issue 2.
18. Fisch B., Rikover Y., Shohat L., Zurgil N., Tadir Y., Ovadia J., Witz I., and Yron T. The relationship between in vitro fertilization and naturally occurring antibodies: evidence for increased production of antiphospholipid autoantibodies. Fertil. Steril. 56 (1991) 718-724
19. Galli M., Luciani D., Bertolini G., and Barbui T. Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature. Blood 101 (2003) 1827-1832
20. Geva E., Yaron Y., Lessing J., Yovel I., Vardinon H., Burke M., and Amit A. Circulating autoimmune antibodies may be responsible for implantation failure in in vitro fertilization. Fertil. Steril. 62 (1994) 802-806
21. Geva E., Amit A., Lerner-Geva L., Azem F., Yovel I., and Lessing J. Autoimmune disorders: another possible cause for in-vitro fertilization and embryo transfer failure. Hum. Reprod. 10 (1995) 2560-2563
22. Gleicher N., el-Roeiy A., Confino E., and Friberg J. Reproductive failure because of antibodies: unexplained infertility and pregnancy wastage. Am. J. Obstet. Gynecol. 160 (1989) 1376-1385
23. Gleicher N., Liu H., Dudkiewicz A., Rosenwaks Z., Kaberlein G., Pratt D., and Karande V. Autoantibody profiles and immunoglobulin levels as predictors of in vitro fertilization success. Am. J. Obstet. Gynecol. 170 (1994) 1145-1149
24. Hasegawa I., Yamanoto Y., Suzuki M., Murakawa H., Kurabayashi T., Takakuwa K., and Tanaka K. Prednisolone plus low-dose aspirin improves the implantation rate in women with autoimmune conditions who are undergoing in vitro fertilization. Fertil. Steril. 70 (1998) 1044-1048
25. Hatasaka H., Branch D., Kutteh W., and Scott J. Autoantibody screening for infertility: explaining the unexplained?. J. Reprod. Immunol. 34 (1997) 137-153
26. Hornstein M., Davis O., Massey J., Paulson R., and Collins J. Antiphospholipid antibodies and in vitro fertilization success: a meta-analysis. Fertil. Steril. 73 (2000) 330-333
27. Johns A., Chamley L., Ockelford P., Pattison N., McKay E., Corkill M., and Hart H. Comparison of tests for the lupus anticoagulant and antiphospholipid antibodies in systemic lupus erythematosus. Clin. Exp. Rheumatol. 12 (1994) 523-526
28. Kaider B., Price D., Roussev R., and Coulam C. Antiphospholipid antibody prevalence in patients with IVF failure. Am. J. Reprod. Immunol. 35 (1996) 388-393
29. Kaider B., Coulam C., and Roussev R. Murine embryos as a direct target for some human autoantibodies in vitro. Hum. Reprod. 14 (1999) 2556-2561
30. Kowalik A., Branch W., Vichnin M., Berkeley A., and Liu H. Midfollicular anticardiolipin and antiphosphatidylserine antibody titers do not correlate with in vitro fertilization outcome. Fertil. Steril. 68 (1997) 298-304
31. Kutteh W. Antiphospholipid antibodies and reproduction. J. Reprod. Immunol. 35 (1997) 151-171
32. Kutteh W., Yetman D., Chantilis S., and Crain J. Effect of antiphospholipid antibodies in women undergoing in-vitro fertilization: role of heparin and aspirin. Hum. Reprod. 12 (1997) 1171-1175
33. Lee S., Park E., Kim S., Chae H., Kim C., and Kang B. Influence of antiphospholipid antibodies on pregnancy outcome in women undergoing in vitro fertilization and embryo transfer. Am. J. Reprod. Immunol. 57 (2007) 34-39
34. Mak I., Brosens J., Christian M., Hills F., Chamley L., Regan L., and White J. Regulated expression of signal transducer and activator of transcription, Stat5, and its enhancement of PRL expression in human endometrial stromal cells in vitro. J. Clin. Endocrinol. Metab. 87 (2002) 2581-2588
35. Martinuzzo M., Igelesias Varela M., Adamczuk Y., Broze G., and Forastiero R. Antiphospholipid antibodies and antibodies to tissue factor pathway inhibitor in women with implantation failure or early and late pregnancy losses. J. Thromb. Haem. 3 (2005) 2587-2589
36. Matalon S., Shoenfeld Y., Blank M., Yacobi S., Blumenfeld Z., and Ornoy A. The effects of IgG purified from women with SLE and associated pregnancy loss on rat embryos in culture. Am. J. Reprod. Immunol. 48 (2002) 296-304
37. Matsubayashi H., Sugi T., Arai T., Shida M., Kondo A., Suzuki T., Izumi S., and McIntyre J. IgG-Antiphospholipid antibodies in follicular fluid of IVF-ET patients are related to low fertilization rate of their oocytes. Am. J. Reprod. Immunol. 55 (2006) 341-348
38. Matsubayashi H., Sugi T., Arai T., Shida M., Kondo A., Suzuki T., Izumi S., and McIntyre J. Antiphospholipid antibodies in serum and follicular fluid-is there a correlation with IVF implantation failure? (Letter). Hum. Reprod. 22 (2007) 3043-3044
39. McIntyre J. Antiphospholipid antibodies in implantation failures. Am. J. Reprod. Immunol. 49 (2003) 221-229
40. Miyakis S., Lockshin M., Atsumi T., Branch D., Brey R., Cervera R., Derksen R., De Groot P., Koike T., Meroni P., Reber G., Shoenfeld Y., Tincani A., Vlachoyiannopoulos P., and Krilis S. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J. Thromb. Haem. 4 (2006) 295-306
41. Nip M., Taylor P., Rutherford A., and Hancock K. Autoantibodies and antisperm antibodies in sera and follicular fluids of infertile patients: relation to reproductive outcome after in-vitro fertilization. Hum. Reprod. 10 (1995) 2564-2569
42. Qublan H., Eid S., Ababneh H., Amarin Z., Smadi A., Al-Khafaji F., and Khader Y. Acquired and inherited thrombophilia: implication in recurrent IVF and embryo transfer failure. Hum. Reprod. 21 (2006) 2694-2698
43. Roussev R., Kaider B., Price D., and Coulam C. Laboratory evaluation of women experiencing reproductive failure. Am. J. Reprod. Immunol. 35 (1996) 415-420
44. Sanmarco M., Bardin N., Camoin L., Beziane A., Dignat-George F., Gamerre M., and Porcu G. Antigenic profile, prevalence, and clinical significance of antiphospholipid antibodies in women referred for in vitro fertilization. Ann. N.Y. Acad. Sci. 1108 (2007) 457-465
45. Sher G., Feinman M., Zouves C., Kuttner G., Maassarani G., Salem R., Matzner W., Ching W., and Chong P. High fecundity rates following in-vitro fertilization and embryo transfer in antiphospholipid antibody seropositive women treated with heparin and aspirin. Hum. Reprod. 9 (1994) 2278-2283
46. Sher G., Zouves C., Feinman M., Maassarani G., Matzner W., Chong P., and Ching W. A rational basis for the use of combined heparin/aspirin and IVIG immunotherapy in the treatment of recurrent IVF failure associated with antiphospholipid antibodies. Am. J. Reprod. Immunol. 39 (1998) 391-394
47. Sher G., Matzner W., Feinman M., Maassarani G., Zouves C., Chong P., and Ching W. The selective use of heparin/aspirin therapy, alone or in combination with intravenous immunoglobulin G, in the management of antiphospholipid antibody-positive women undergoing in vitro fertilization. Am. J. Reprod. Immunol. 40 (1998) 74-82
48. Sher G., Fisch J., Maassarani G., Matzner W., Ching W., and Ching P. Antibodies to phosphatidylethanolamine and phosphatidylserine are associated with increased natural killer cell activity in non-male factor infertility patients. Hum. Reprod. 15 (2000) 1932-1936
49. Stern C., Chamley L., Hale L., Kloss M., Speirs A., and Baker H. Antibodies to beta-2 glycoprotein 1 are associated with in vitro fertilization implantation failure, as well as recurrent miscarriage: results of a prevalence study. Fertil. Steril. 70 (1998) 187-188
50. Stern C., Chamley L., Norris H., Hale L., and Baker H. A randomized, double-blind, placebo-controlled trial of heparin and aspirin for women with in vitro fertilization implantation failure and antiphospholipid or antinuclear antibodies. Fertil. Steril. 80 (2003) 376-383
51. Sthoeger Z., Mozes E., and Tartakovsky B. Anti-cardiolipin antibodies induce pregnancy failure by impairing embryonic implantation. Proc. Natl. Acad. Sci. U.S.A. 90 (1993) 6464-6467